A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol
Titel:
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol
Auteur:
Spicer, J. Blais, N. Owen, S. Robinson, A.G. Chu, Q. Labbe, C. Shieh, B. Brown-Walker, P. Sederias, J. Jensen, K. Farago, A.F. Tsao, M.-S. Cottrell, T.R. Kidane, B. Laurie, S. Juergens, R. Bradbury, P.A. Tu, W. Gaudreau, P.-O.